| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70564 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 |
| filingDate |
2003-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d209b1c0b3cde34713890615ebb4a06c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59a9751feb0d05d060ce7b090db6f340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_080ed24731cac2c3dc0120f3a7c897fc |
| publicationDate |
2005-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005048133-A1 |
| titleOfInvention |
Methods for treating ischemic disorders using carbon monoxide |
| abstract |
The present invention provides for a method for treating an ischemic disorder in a subject which comprises administering to the subject a pharmaceutically acceptable form of a selectin antagonist in a sufficient amount over a sufficient time period to prevent white blood cell accumulation so as to treat the ischemic disorder in the subject. The invention further provides a method for treating an ischemic disorder in a subject which comprises administering to the subject carbon monoxide gas in a sufficient amount over a sufficient period of time thereby treating the ischemic disorder in the subject. The invention further provides a method for treating an ischemic disorder in a subject which comprises administering to the subject a pharmaceutically acceptable form of inactivated Factor IX in a sufficient amount over a sufficient period of time to inhibit coagulation so as to treat the ischemic disorder in the subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003219497-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004005367-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008167609-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006127501-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9068001-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7989650-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004258772-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005255178-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002155166-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10716806-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8097585-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8236339-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9556266-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011237546-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007207217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007219120-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9023402-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018303872-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004052866-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006233890-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8389572-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9163044-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004131703-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7968605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9522163-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004228930-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006115542-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008108894-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7678390-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7687079-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8945565-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9062089-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9738884-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006055498-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7964220-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7981448-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7364757-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7238469-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7691416-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8377440-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9611286-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006055498-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003219496-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005250688-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008026984-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003039638-A1 |
| priorityDate |
1996-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |